The OCT1, NTCP, OATP1A1, OATP1A2, and OATP1A4 promoted the drug uptake transporter (Kim et al., 2004), the NAFLD model was reduced, and the drug absorption was restrained. Here, SLCO1A2 is linked to metabolic dysfunction-associated steatotic liver disease.